Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program

Alexander Drilon, Anne A. Eaton, Katja Schindler, Mrinal M. Gounder, David R. Spriggs, Pamela Harris, S. Percy Ivy, Alexia Iasonos, Mario E. Lacouture, David M. Hyman

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry